Fosun Pharma Announces 2020 Annual Results: Accelerated Transformation and Implementation of Multiple Innovation Achievements Significantly Improved Global Commercialization Capability

Category:

Company News

Author:

Source:

Add time:2021-03-30 16:00

Summary:

(March 29, 2021, Shanghai, China) On March 29, 2021, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (abbreviated as “Fosun Pharmaceutical” , Or “The Group”, stock code: 600196.SH; 02196.HK) announced the full-year 2020 (“reporting period”) business performance, and announced the 2020 corporate social responsibility report at the same time.

Related News

■

Inclusive access upgraded! Shenyang Hongqi Pharmaceutical’s bedaquiline has been approved—making it the first domestic company to offer a complete portfolio of BPaL/M regimens.

—

2026-05-13

■

Yes! We can end tuberculosis: more equitable treatment, giving more patients hope.

■

Forging a New Core, Benefiting the World, Soaring with Global Influence—Shenyang Hongqi Pharmaceutical’s 2026 Annual Work Conference Concludes Successfully

■

Major News: Puruini® has been included in the 2025 National Reimbursement Drug List, marking a new era of universal access to treatment for drug-resistant tuberculosis.

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Add：Shenyang Hunnan New District envelope 6th Street

Tel:+86 24 2378 6268-8012

SEO tags

Business license

+86-24-23786268

hongqi@hongqipharma.com